Influenza A virus A/Tasmania/503/2020 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen".
- Primary indication
- In combination with other influenza virus subtypes A and types B strains, this Influenza A viral strain is used for active immunization of adults and children aged 6 months or older for the prevention of...Curator reviewed · 2 structured indications
- First approval
- United States, 2020
Resolves to
What you can answer from here — as of April 25, 2026
Which other approved drugs treat the same conditions as Influenza A virus A/Tasmania/503/2020 (H3N2) antigen (MDCK cell derived, propiolactone inactivated), and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account